Literature DB >> 7200025

Response to second line chemotherapy in ovarian cancer of epithelial origin.

J Menczer, S Baitner, M Modan, S Chaitchik, H Brenner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7200025     DOI: 10.1016/0014-2964(81)90005-0

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


× No keyword cloud information.
  2 in total

Review 1.  Developing new drugs for ovarian cancer: a challenging task in a changing reality.

Authors:  R M Canetta; S K Carter
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

2.  Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer.

Authors:  A du Bois; H G Meerpohl; H Madjar; D Spinner; P Dall; J Pfisterer; T Bauknecht
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.